Phase 2 Trial of Induction Gemcitabine, Oxaliplatin, and Cetuximab Followed by Selective Capecitabine Based Chemoradiation in Patients With Borderline Resectable or Unresectable Locally Advanced Pancreatic Cancer

PURPOSE: To evaluate, in a phase 2 study, the safety and efficacy of induction gemcitabine, oxaliplatin, and cetuximab followed by selective capecitabine-based chemoradiation in patients with borderline resectable or unresectable locally advanced pancreatic cancer (BRPC or LAPC, respectively). METHO...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Esnaola, Nestor F., Chaudhary, Uzair B., O'Brien, Paul, Garrett-Mayer, Elizabeth, Camp, E. Ramsay, Thomas, Melanie B., Cole, David J., Montero, Alberto J., Hoffman, Brenda J., Romagnuolo, Joseph, Orwat, Kelly P., Marshall, David T.
Format: Artigo
Idioma:Inglês
Publicat: 2014
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4120643/
https://ncbi.nlm.nih.gov/pubmed/24606850
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2013.12.030
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars